Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence

from The Readout Loud · host STAT

Why are biotech stocks in the dumps? Is the latest in cancer care overhyped? And what does "folie à deux" mean?

Episode metadata supplied by the publisher feed · Published Nov 1, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 35: Biotech's October slump, the precise cost of precision, and breaking postpartum silence

0:00 26:12

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 26 minutes long.

This episode was published on November 1, 2018.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!